Early research (Phase 1)Study completedNCT02815644What this trial is testingEmpa/Lina FDC Food Effect Study (Japan)Who this might be right forHealthy Boehringer Ingelheim 22
Early research (Phase 1)Study completedNCT03922633What this trial is testingA Single Intravenous Dose of E3112 in Japanese Healthy Adult Male ParticipantsWho this might be right forHealthy Male Participants EA Pharma Co., Ltd. 24
Early research (Phase 1)Study completedNCT01520987What this trial is testingPharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian SubjectsWho this might be right forParkinson Disease Bial - Portela C S.A. 105
Early research (Phase 1)Study completedNCT04133116What this trial is testingLY3471851 in Healthy ParticipantsWho this might be right forHealthy Nektar Therapeutics 36
Early research (Phase 1)Study completedNCT01569126What this trial is testingLY110140 in Healthy Japanese Male ParticipantsWho this might be right forHealthy Volunteer Eli Lilly and Company 56
Early research (Phase 1)Study completedNCT05440136What this trial is testingA Safety Study of LY3462817 in Healthy Japanese and Non-Japanese ParticipantsWho this might be right forHealthy Eli Lilly and Company 33
Early research (Phase 1)Study completedNCT01725009What this trial is testingMultiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy MalesWho this might be right forHealthy Volunteers UCB Japan Co. Ltd. 32
Early research (Phase 1)Study completedNCT05037409What this trial is testingInvestigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy ParticipantsWho this might be right forHealthy Pfizer 13
Early research (Phase 1)Study completedNCT03236493What this trial is testingSafety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy VolunteersWho this might be right forHealthy Pfizer 8
Early research (Phase 1)Study completedNCT00820092What this trial is testingXerecept Intravenous Dose Escalation in Japanese and Caucasian VolunteersWho this might be right forEdema Celtic Pharma Development Services 38
Early research (Phase 1)Ended earlyNCT00875628What this trial is testingInvestigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult VolunteersWho this might be right forHealthy Volunteers Pfizer 24
Early research (Phase 1)Study completedNCT01575587What this trial is testingAssess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese MenWho this might be right forPharmacology Janssen Research & Development, LLC 51
Early research (Phase 1)Study completedNCT01299298What this trial is testingEvaluate the Pharmacokinetics, Safety, and Tolerability of Single Doses of Mipomersen in Japanese Healthy VolunteersWho this might be right forHealthy Volunteer Kastle Therapeutics, LLC 20
Early research (Phase 1)Study completedNCT03859414What this trial is testingPK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. CaucasiansWho this might be right forAsthmaChronic Obstructive Pulmonary Disease Chiesi Farmaceutici S.p.A. 32
Early research (Phase 1)Study completedNCT02176252What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese SubjectsWho this might be right forHealthy Volunteer Ardelyx 83
Early research (Phase 1)Study completedNCT06868082What this trial is testingInvestigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese ParticipantsWho this might be right forHealthy Uniquity One (UNI) 32
Early research (Phase 1)Study completedNCT00479297What this trial is testingStudy Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese MalesWho this might be right forAlzheimer Disease Wyeth is now a wholly owned subsidiary of Pfizer 72
Early research (Phase 1)Study completedNCT05877222What this trial is testingTrial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese ParticipantsWho this might be right forHealthy Idorsia Pharmaceuticals Ltd. 38
Early research (Phase 1)Study completedNCT07361354What this trial is testingAn Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)Who this might be right forHealthy ParticipantsPharmacokinetic Study Angitia Incorporated Limited 28
Early research (Phase 1)Study completedNCT02398591What this trial is testingInvestigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult ParticipantsWho this might be right forHealthy Janssen Sciences Ireland UC 24